Skip to main content
OpenTrials
Completed

NCT Number: NCT03321227

Effect of Eggs and Egg Components on Cognitive Performance and Appetite in School-aged Children

The purpose of the present study is to determine the effects of eggs and egg components on cognitive performance and appetite in children aged 9-14 years, as well as to identify the underlying physiological mechanisms in this relationship.

Completed

Looking for future studies?

Notify Me

Key information

Age range

9 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

School of Nutrition, Ryerson University

Toronto, Ontario, M5B 2K3, Canada

About this study

Children will be asked to refrain from exercising the morning of their test day and inform researchers of any illness. Following a 12-hour overnight fast, children will consume a standardized breakfast of a cereal bar, fruit cup and orange juice at home (total 330 kcal). Children will be asked to avoid consumption of any other food, with the exception of water, until arrival at the laboratory 3 hours later.

At the laboratory, five treatments of: (a) 2 whole eggs, (b) 2 egg whites, (c) 2 egg yolks, (d) full fat yogurt isocaloric to the 2 whole eggs, and (e) snack skipping will be provided to children 9-14 years on separate days at least 7 days apart. Cognitive performance, subjective emotion/mood, and subjective appetite will be measured for 90-minutes following snack consumption (n=25). Cognitive performance assessments will include learning and memory, spatial memory, attention and processing speed, and executive functions. In a subgroup of individuals (n=10), glucose, insulin, incretin hormones (glucagon like peptide1(GLP1) and gastric inhibitory polypeptide (GIP)),dipeptidyl peptidase 4 (DPP4), amino acids, fatty acids, and choline will be measured for 90-minutes following snack consumption.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be between 9 and 14 years of age
  • be healthy, and have been born at term
  • healthy body weight (between the 5th and 85th BMI percentile for age and gender)

Exclusion criteria

  • children with food sensitivities or allergies to eggs, egg-products, dairy and wheat
  • children with any diagnosed learning, emotional, or behavioral disabilities
  • children on medications that may influence cognitive performance

Treatment and study plan

Snack skipping

Other

No snack provided

Whole Eggs

Other

2 whole large eggs scrambled, provided as a snack

Egg Whites

Other

2 egg whites scrambled, provided as a snack

Egg Yolks

Other

2 egg yolks scrambled, provided as a snack

Yogurt

Other

A serving of full fat yogurt that is isocaloric to the 2 whole eggs

Primary outcomes

  1. Change in memory from baseline

    Time frame: 15, 30, 60, and 90 minutes

    One of five word lists composed of 15 words will be audio-visually presented to children. The majority of the words will be one syllable, and four words in each list will be two syllables long. The list will be presented at baseline and the children will be asked to recall as many words as possible at each time-point. The list will be presented for 2.5 minutes, and children will have 2 minutes for both immediate and delayed recall.

  2. Change in spatial working memory from baseline

    Time frame: 0, 15, 30, 60, and 90 minutes

    Assessed using a spatial pattern recognition test via the Membrain application. The test consists of a series of subtests where children will be presented a picture with patterns to study, and asked to identify a picture with the same pattern from a group of four images. This test will be at each time-point and takes approximately 1 minute to complete.

  3. Change in attention from baseline

    Time frame: 0, 15, 30, 60, and 90 minutes

    The continuous performance task (CPT) will be completed via the Membrain application. During the CPT task, children will be given a sequence of two letters to identify; for example respond to the detection of the letter "X" only when it is preceded by the letter "A". This task will be at each time-point and will take 3 minutes total to complete.

  4. Change in executive function from baseline

    Time frame: 0, 15, 30, 60, and 90 minutes

    The Stroop task will be completed via the Membrain application. Children will be presented with a list of words presented in colors that match the word (congruent, the word 'red' presented in red) or colors that do not match the word (incongruent, the word 'red' presented in blue). Children will be asked to identify the color of the word, not the word itself. The task is scored for the number of correct and incorrect colors identified, as well as total time to completion. This test will be at each time-point and will take 1 minute to complete.

Secondary outcomes

  1. Change from baseline mood

    Time frame: 0, 15, 30, 60, and 90 minutes

    Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.These emotions will be seperated into three categories including, subjective emotions (aggressive, angry, excited, disappointed, and frustrated), global vigour and affect (alert, sad, tense, effort, happy, weary, calm and sleepy), and wellness. These sub scales will be combined to compute an average total score for each category.

  2. Change from baseline subjective appetite

    Time frame: 0, 15, 30, 60, and 90 minutes

    Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings. Average appetite will combine four questions (desire to eat, hunger, fullness, and prospective food consumption) to calculate the score.

  3. Change from baseline cholecystokinin (CCK)

    Time frame: 0, 15, 30, 60, and 90 minutes

    Blood CCK (pmol/L). CCK concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  4. Change from baseline dipeptidyl peptidase 4 (DPP4)

    Time frame: 0, 15, 30, 60, and 90 minutes

    Blood DPP4 (ng/mL). DPP4 concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  5. Change from baseline glucagonlike peptide1 (GLP1)

    Time frame: 0, 15, 30, 60, and 90 minutes

    Blood GLP1 (pmol/L). GLP1 concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  6. Change from baseline insulin

    Time frame: 0, 15, 30, 60, and 90 minutes

    Blood insulin (pmol/L). Insulin concentration in serum will be determined in duplicate via enzymelinked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  7. Change from baseline glycemic response

    Time frame: 0, 15, 30, 60, and 90 minutes

    Blood glucose will be measured in whole blood using YSI 2300 STAT PLUS (YSI Incorporated, Yellow Springs, OH)

  8. Change from baseline amino acids

    Time frame: 0, 15, 30, 60, and 90 minutes

    From plasma blood samples. Amino acids will be determined using the pre-column derivatization HPLC procedure. A plasma sample will be de-proteinizied with a 5-sulfosalicyclic acid solution, then centrifuged at 4°C and 18,400 G for 15 minutes. The amino acids will be derivatized from the sample with ortho-phthaldehyde reagent. The sample will then be analyzed using the Perkin Elmer Series HPLC System in the Ryerson University Analytical Centre.

  9. Change from baseline fatty acids

    Time frame: 0, 15, 30, 60, and 90 minutes

    From plasma blood samples. Fatty acids will be assessed via gas chromatography, an effective method to measure both the proportions and concentrations of fatty acids in plasma. A plasma sample will be prepared by trans-esterification of total lipid aliquots with a MeOH/HCl mixture and n-hexane. The sample will then be analyzed using the Perkin Elmer Auto-System in the Ryerson University Analytical Centre.

  10. Change from baseline choline

    Time frame: 0, 15, 30, 60, and 90 minutes

    From plasma blood samples. Will be analyzed for choline using a fluorimetric assay; free choline will be oxidized by choline oxidase to betaine and H2O2 that reacts with a specific dye to form a pink colored product. The fluorescence intensity at 530/585 nm is directly proportional to the choline concentration in the sample.

Sponsors and collaborators

Lead sponsor

Toronto Metropolitan University

Other

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Oct 25, 2017
Registry last updated
Mar 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.